Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
ZOLOFT UPJOHN CANADA ULC Anticipated shortage 100MG Updated Report 2022-07-04 161625
XANAX UPJOHN CANADA ULC Actual shortage 1MG Updated Report 2022-07-04 162663
IRINOTECAN HYDROCHLORIDE INJECTION USP PFIZER CANADA ULC Actual shortage 20MG Updated Report 2022-07-04 151106
CEFTRIAXONE INJECTION, USP BAXTER CORPORATION Actual shortage 1000MG Updated Report 2022-07-04 162666
PROCYTOX TAB 25MG BAXTER CORPORATION Actual shortage 25MG Updated Report 2022-07-04 161841
TECHNETIUM TC 99M TSC GE HEALTHCARE CANADA INC Anticipated shortage 2MG Updated Report 2022-07-04 163670
FOQUEST ELVIUM LIFE SCIENCES Actual shortage 100MG Updated Report 2022-07-04 151791
BIPHENTIN ELVIUM LIFE SCIENCES Actual shortage 50MG Updated Report 2022-07-04 157748
BIPHENTIN ELVIUM LIFE SCIENCES Actual shortage 80MG Updated Report 2022-07-04 157373
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG PURDUE PHARMA Anticipated shortage 3MG Updated Report 2022-07-04 163413

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
SELECTBAG ONE (AX2525G) BAXTER CORPORATION To be discontinued 36.8G 37.3G 20.3G 36.0G 220.0G Updated Report 2022-07-04 125880
PRIMAXIN 500 MERCK CANADA INC Discontinued 500MG 500MG Updated Report 2022-07-01 149907
VENTOLIN NEBULES P.F. - 5MG/2.5ML GLAXOSMITHKLINE INC Discontinued 5MG Updated Report 2022-06-30 130636
CLINIMIX E BAXTER CORPORATION Discontinued 205MG 261MG 58.5MG 24MG 16.6G 365MG 280MG 290MG 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG Updated Report 2022-06-30 118607
ZOFRAN NOVARTIS PHARMACEUTICALS CANADA INC To be discontinued 4MG New Report 2022-06-29 163685